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 O R I G I N A L R E S E A R C H
Pediatric blood transfusion practices at a regional referral
hospital in Kenya
Helen M. Nabwera,1,2 Greg Fegan,1,3,4 Jay Shavadia,5 Douglas Denje,6 Kishor Mandaliya,6,7
Imelda Bates,2 Kathryn Maitland,1,8 and Oliver W. Hassall1,2,9
BACKGROUND: Severe anemia in children is a major
public health problem in sub-Saharan Africa. In this study
we describe clinical and operational aspects of blood
transfusion in children admitted to Coast Provincial
General Hospital, Kenya.
STUDY DESIGN AND METHODS: This was an
observational study where over a 2-year period,
demographic and laboratory data were collected on all
children for whom the hospital blood bank received a
transfusion request. Clinical data were obtained by
retrospective review of case notes over the first year.
RESULTS: There were 2789 requests for blood for
children (median age, 1.8 years; interquartile range
[IQR], 0.6-6.6 years); 70% (1950) of the samples were
crossmatched with 85% (1663/1950) issued. Ninety
percent (1505/1663) were presumed transfused. Median
time from laboratory receipt of request to collection of
blood was 3.6 hours (IQR, 1.4-12.8 hr). Case notes of
590 children were reviewed and median pretransfusion
hemoglobin level was 6.0 g/dL (IQR, 4.2-9.1 g/dL).
Ninety-four percent (186) were transfused “appropriately”
while 52% (120) were transfused “inappropriately.” There
was significant disagreement between the clinical and
laboratory diagnosis of severe anemia (exact McNemar’s
test; p< 0.0001). Antimalarials were prescribed for 65%
(259) of children who received blood transfusions but
only 41% (106) of these had a positive blood film.
CONCLUSION: In this setting, clinicians often order
blood based on the clinical impression of “severe
anemia.” This has implications for laboratory workload
and the blood supply itself. However, the majority of
children with severe anemia were appropriately
transfused. The use of antimalarials with blood
transfusions irrespective of blood film results is common
practice.
S
evere anemia resulting in significant morbidity
and mortality is common in children in sub-
Saharan Africa and urgent blood transfusion is a
lifesaving intervention.1-4 Blood shortages are
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common in low- and middle-income countries and delays
in the acquisition and administration of blood have con-
tributed significantly to in-hospital mortality of children
with severe anemia.5
International clinical transfusion guidelines for set-
tings with limited resources are restrictive and reflect his-
torical inadequacies in the blood supply. Since 2005, the
World Health Organization (WHO) recommendation has
been to reserve transfusion for those children with pro-
found anemia (hemoglobin [Hb] 4 g/dL; Hb 10 g/dL
in neonates) and in those where anemia is less severe (Hb
4-6 g/dL) only when signs of critical illness are present.
Whole blood transfusion of 20 mL/kg is recommended
(10 mL/kg red blood cells [RBCs] preferred when available
for children with heart failure and severe acute malnutri-
tion) and for children with severe acute malnutrition
10 mL/kg whole blood and furosemide (1 mg/kg intrave-
nously) at the start of the transfusion.6 In contrast, in
high-income settings transfusion guidelines for hemoglo-
bin (Hb) thresholds in children and neonates are between
7 and 12 g/dL depending on the clinical context and RBCs
are routinely available and used.7,8
To prevent the transmission of malaria by blood
transfusion in endemic countries, international guide-
lines recommend donor selection and deferral strategies
or laboratory screening for malaria of all blood dona-
tions.9 In practice, these two strategies are rarely imple-
mented and a third approach is also recommended—the
administration of malarial chemoprophylaxis after trans-
fusion, especially to the most vulnerable, that is, preg-
nant women and children.10 The Kenya National Blood
Transfusion Services (KNBTS) that was established in
2001 has adopted this policy, which has not been revised
in their latest guidance from 2004.11 In addition, blood
is routinely screened for human immunodeficiency
virus, for hepatitis B and C, and for syphilis but not for
bacterial infection.11,12
In the past decade the establishment of national
blood transfusion services with impetus from the WHO
“Goal of African Regional Blood Safety by 2012” and the
mobilization of voluntary, nonremunerated blood donors
have significantly improved the supply and safety of blood
in many countries in sub-Saharan Africa, including Ken-
ya.12,13 Nevertheless, blood remains a limited and poten-
tially hazardous resource and one that should be given in
a timely and safe manner to only those that need it.14,15
There are few data relating to the clinical and operational
aspects of pediatric blood transfusion in Kenya since the
introduction of the national blood service in 2001.3,4,16,17
The aim of this observational study was to describe clini-
cal and laboratory practice and identify potential areas for
intervention to improve the efficacy and safety of blood
transfusion for children admitted to the second largest
public referral hospital in Kenya.
MATERIALS AND METHODS
The study was conducted at Coast Provincial General Hos-
pital (CPGH) in Mombasa. The Mombasa Regional Blood
Transfusion Centre, which is one of the six regional cen-
ters of the KNBTS, is adjacent to CPGH and has provided
the hospital with whole blood from nondirected donors
since 2002. Blood supplied by the Mombasa Regional
Blood Transfusion Centre has supplanted the hospital’s
replacement donor system and blood shortages are less
frequent.
All requests to the hospital laboratory for blood for
transfusion for children aged less than 14 years were iden-
tified prospectively over a 24-month period. Data relating
to transfusion requests, crossmatches, and issues were
extracted from existing handwritten ledgers in the CPGH
blood bank. There was no “group and save” option on the
transfusion request form and most requests were marked
“urgent.” There were no pediatric blood packs and blood
volumes of less than 1 unit (450 mL) issued by the blood
bank were drawn from standard blood packs into a dry
bag.14 The study was undertaken from May 2005 to April
2007 and for the first 12 months, clinical case notes were
sought from the hospital records department for all chil-
dren for whom blood had been requested after they had
been discharged or died. The hospital records department
archived the notes of children who had died separately
from those discharged alive. Data extraction relating to
clinical case management including the clinician’s indica-
tion for requesting blood, the volumes of blood they
requested and prescribed, as well as whether or not the
child received the blood transfusion was undertaken by
two clinicians (OWH, JS) using a predefined template.
Data were entered onto an electronic database (Epi-
data)18 and exported to statistical software (STATA 11.2,
StataCorp) for analysis. Where the laboratory pretransfu-
sion Hb results were recorded in the notes they were used
to classify children as having severe anemia or not accord-
ing to the WHO criteria.5 Weight-for-age z-scores (WAZ)
were calculated using WHO 2006 child growth
standards.19
We calculated a recognized measure of the efficiency
of blood ordering and utilization—the “crossmatch-to-
transfusion ratio” defined as the number of blood units
crossmatched divided by the number of units trans-
fused.20 We also calculated the “request-to-issue ratio” as
the number of blood units requested divided by the num-
ber of units transfused to assess for mismatch between
clinician’s requests for blood and blood bank’s issuing of
blood.
Fisher’s exact and chi-square tests were used to com-
pare categorical variables; continuous variables were sum-
marized by means with 95% confidence intervals (CIs)
and differences tested for significance using the t test.
Nonnormally distributed data were summarized using
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medians and interquartile ranges (IQRs), and differences
were tested for significance using the Wilcoxon-Mann-
Whitney U test. We used McNemar’s test to assess agree-
ment between clinical and laboratory diagnosis of severe
anemia. We estimated the positive percent agreement and
the negative percent agreement using the laboratory diag-
nosis of severe anemia as a reference. A p value of less
than 0.05 was considered significant.
RESULTS
From May 2005 to April 2007, there were 17,558 pediatric
admissions to CPGH and 2789 pediatric blood transfusion
requests. Blood was crossmatched for 1950 (70%) of the
requests and in 1505 cases crossmatched blood was
issued from the blood bank and not returned. Therefore,
77% (1505/1950) of crossmatched blood and 54% (1505/
2789) of requests for transfusion were presumed trans-
fused (crossmatch-to-transfusion ratio, 1.3; request-to-
issue ratio, 1.9). In 156 cases, crossmatched blood was col-
lected from the blood bank but returned unused. Of the
2514 transfusion requests made to the blood bank where
the blood volume for whole blood was recorded, 50%
were for less than 1 unit, 38% were for 1 unit, and 12%
were for greater than 1 unit. Of the 1845 crossmatches by
the blood bank where the blood volume was recorded,
45% were for the issue of either less than 1 unit (44%) or
greater than 1 unit (1%; 62% vs. 45%; chi-square;
p< 0.0001). Fifty-five percent of the blood issued by the
blood bank was for 1 unit whereas only 38% of requests
were for 1 unit (55% vs. 38%; Fisher’s exact test;
p< 0.0001). The majority of requests (50%) made were for
less than 1 unit of blood (Table 1).
Despite repeated attempts, it was only possible to
retrieve case notes for 590 (45%) of the 1322 children for
whom blood was requested over the first 12 months of the
study; 67% (396/590) of these children received a blood
transfusion. A clinical diagnosis of severe anemia by the
attending clinician was recorded in 48% (281/590) of the
case notes, and 88% (248/281) of these were transfused.
Of the 492 children who had a pretransfusion Hb recorded
in their notes, only 66% (327/492) had severe anemia
using the WHO definition and 88% (287/327) of these
were transfused (Table 2). Twenty-four percent (141/590)
of children had neither a clinical nor a laboratory diagno-
sis of severe anemia and 27% (38/141) of these were trans-
fused. The median pretransfusion Hb concentration was
10.2 (IQR, 6.5-13.2) g/dL in children who were 3 months
old or younger and 5.6 (IQR, 4.0-8.4) g/dL in those over 3
months of age.
We excluded 84 children aged less than 3 months of
age and 23 children with no recorded data on “clinical
severe anemia” from subsequent analyses as the WHO
transfusion guidelines did not apply to this younger age
group. The clinical impression of “severe anemia” was
used as a proxy for the presence of one or more signs of
critical illness (clinically detectable dehydration, shock,
impaired consciousness, heart failure, deep labored
breathing, very high malaria parasitemia). This clinical
feature was recorded consistently and therefore allowed
us to estimate adherence to WHO guidelines for
TABLE 1. Pediatric transfusion requests and
crossmatches over a 2-year period at CPGH, Kenya
Characteristics Requested Crossmatched
Number (%) 2789 (100) 1950 (100)
Age (years), mean (IQR) 1.75 (0.6-6.0) -
Female, n (%) 1188 (43) -
Blood volumes* - -
Observations, n (%) 2514 (90) 1847 (95)
Median, mL (IQR) 400 (200-450) 450 (200-450)
Range, mL 10-1800 2-900
Mean, mL (6SD) 370 (6238) 338 (6145)
<1 unit, n (%) 1267 (50)† 812 (44)†
1 unit, n (%) 948 (38)† 1022 (55)†
>1 unit, n (%) 299 (12)† 11 (1)†
*Volumes of 1 unit and greater are multiples of 1 unit (450 mL).
†Fisher’s exact test for difference between volumes requested
and prescribed, p< 0.0001.
TABLE 2. Summary characteristics of all children whose case notes were reviewed
Characteristics N5 590 Transfused (n5396) Furosemide (n5349) Antimalarial (n5 294)
Age (years), median (IQR) 1.38 (0.5-4.0) - - -
Weight (kg), median (IQR) 8.0 (5.5-12.0) - - -
Pretransfusion Hb recorded, n (%) 492 (83) - - -
Age< 3 months, n (%) 84 (14) 39 (46) 38 (45) 10 (12)
Severe anemia (clinical), n (%) 281 (48*) 248 (88) 231 (82) 216 (77)
Severe anemia (laboratory), n (%) 327 (66†) 287 (88) 246 (75) 221 (68)
Positive blood film, n (%) 137 (23‡) 116 (85) 106 (77) 118 (86)
WAZ score<23§ 112 (29jj) 68 (54) 63 (56) 51 (46)
Discharged alive 458 (78) 315 (69) 260 (57) 236 (52)
*Denominator5584.
†Denominator5496.
‡Denominator5332.
§Computed using WHO growth standards 2006.
jjDenominator5 380.
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transfusion (Table 3). Of the 197 children with either labo-
ratory Hb level of not more than 4 or 4 to 6 g/dL and a
clinical impression of severe anemia, 186 (94%) were
transfused appropriately. Of the 232 children with either a
Hb level of 4 to 6 g/dL and no severe anemia or a Hb level
of more than 6 g/dL, 120 (52%) were transfused inappro-
priately (Table 3).
Time intervals from the receipt of a transfusion request
to the issue of crossmatched blood were significantly
shorter in those children with a clinical diagnosis of severe
anemia compared to those without (Wilcoxon rank-sum
test; p5 0.01), but this was not the case in those children
with a laboratory diagnosis of severe anemia (Wilcoxon
rank-sum test; p5 0.44). There was strong evidence of dis-
agreement between the clinical and laboratory diagnosis of
severe anemia (exact McNemar’s test; p< 0.0001). Using
the laboratory diagnosis as the reference, the positive per-
cent agreement and negative percent agreement for clinical
diagnosis were 69.2% (95% CI, 63.8%-74.1%) and 83.2%
(95% CI, 75.7%-88.7%), respectively (Table 4).
The median volume of whole blood prescribed was
200 mL (IQR, 150-336 mL), and the median volume pre-
scribed by weight was 22.1 mL/kg (IQR, 20-30 mL/kg;
Table 4). Eighty-one percent (334/410) of blood volumes
prescribed by clinicians were for less than 1 unit, and 15%
(60/410) were for 1 unit (450 mL). In 33% (118/354) of
cases, clinicians requested a larger volume of whole blood
than that which they had prescribed. Of blood transfusion
requests made by clinicians and received in the blood
bank, 66% (293/442) were for less than 1 unit and 27%
(119/442) for 1 unit. Of the 367 crossmatches by the blood
bank, 47% (172) were for the issue of 1 unit (Table 5).
Of the 396 children whose case notes were reviewed
and who were transfused, 259 (65%) were prescribed an
antimalarial and of those who were prescribed antimalar-
ials, 106 (41%) had a positive blood film, 97 (38%) had a
negative blood film, and 55 (21%) had no result of a blood
film recorded. Furosemide was prescribed for 318 (81%)
of the children transfused and for 27 (7%) of those who
were not. Of the 112 children with WAZ of less than 23
(indicating that they were severely underweight), 71 were
transfused. Of these, one (0.5%) received 10 mL/kg or less
of whole blood (median, 25.8 mL/kg; IQR, 20-32 mL/kg),
and 63 (77%) were prescribed furosemide (Table 2).
DISCUSSION
To our knowledge this is the first detailed description of
the operational aspects of clinical and laboratory blood
transfusion practice in children (n5 2789) admitted to a
Kenyan hospital since the KNBTS was established in 2001.
Blood transfusion is an integral part of acute pediatrics
where children’s lives are saved if they receive appropriate
blood transfusions in a timely manner.8 However, it can
also be a very costly intervention if done inappropriate-
ly.15,17 A clear understanding of these operational aspects
is therefore important in improving the efficiency and
delivery of this vital service.
Ninety-six percent of children with laboratory-
confirmed severe anemia were transfused appropriately
but there was significant overtransfusion of children who
did not fulfill the criteria for transfusion (52%), that is, 120
inappropriate transfusions in children over a period of a
year. The data indicate that the clinicians were likely to be
TABLE 3. Appropriate use of blood
Hb (g/dL) Number (%) Transfused (%)
Clinical severe
anemia? (%) Transfused (%)
Not
transfused
Request to issue time (hr),
median (IQR)
4 109 (26) 105 (96) Yes 98 (89) 96 (98) 2 5.4 (2.3-12.1)
No 11 9 2 3.6 (1.7-13.5)
4-6 122 (29) 111 (91) Yes 88 (72) 81 (92) 7 4.5 (1.6-12.5)
No 34 30 4 11.2 (4.6-22.6)
> 6 196 (46) 90 (64) Yes 44 (22) 34 (77) 10 5.8 (1.5-18.2)
No 152 56 96 6.2 (2.4-21.3)
Total 424 342 - - 121 -
TABLE 4. Comparison between laboratory and clinical diagnosis of severe anemia
Clinical
diagnosis
(n5427)
Laboratory
diagnosis
(n5427)
p value*
Overall proportion of
agreement (95% CI)†
Positive percent
agreement (95% CI)†
Negative percent
agreement (95% CI)†Yes No
Yes 209 21 <0.0001 73.3 (68.9-77.3) 69.2 (63.8-74.1) 83.2 (75.7-88.7)
No 93 104
*Exact McNemar’s test.
†Wilson 95% CIs. Positive percent agreement and negative percent agreement were estimated using laboratory diagnosis as the reference.
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deciding to transfuse on the basis of their clinical judg-
ment without laboratory confirmation of the level of ane-
mia. This may have been because they did not trust the
Hb results, the results did not come back quickly enough,
or that they did not send the Hb tests and/or wait for the
result.1,21 The use of pallor to screen for severe anemia
has good specificity (88%-95%) but poor sensitivity (27%-
50%) and results in patients who are not severely anemic
receiving unnecessary transfusions.22,23 There is therefore
a need to have quality assurance mechanisms to improve
the accuracy and rapidity of Hb results available through
the laboratory to clinicians. Clinicians would then be able
to demonstrate that their blood request is based on a lab-
oratory Hb level. For urgent requests this check of Hb
could be done by the blood bank staff and senior staff
should query clinicians about the need for transfusion if
the Hb is not low enough. This would dissuade clinicians
from requesting for blood based on a clinical diagnosis
alone. Overordering of blood wastes a scarce resource as
well as the blood bank staff time, which contributes to
delays in crossmatching of blood. However, we recognize
that the provision of a reliable rapid Hb result may not
necessarily dissuade clinicians from relying on their clini-
cal diagnosis of severe anemia, as has been shown with
the use of malaria rapid diagnostic tests and prescribing
of antimalarials for patients with negative results.24 More
research is needed to explore why and how behavior
might be changed.
Clinicians generally prescribed blood according to
the WHO recommendation of 20 mL/kg,5 but 33% of
requests were for larger volumes of blood than were actu-
ally prescribed on the patient charts. This may suggest a
lack of confidence between clinical and laboratory serv-
ices—whereby clinicians’ expectation that the laboratory
might ration the transfusion volume to be issued leads
them to increase the requested volumes in the hope of
receiving an appropriate amount. Alternatively, this dis-
crepancy may be due to the fact that blood request proce-
dures may not have been updated in line with the WHO
guidelines and therefore blood is ordered in units and not
in milliliters, therefore resulting in larger volumes being
requested. Training of clinicians in the indications for
blood transfusions in children and improved communica-
tion and working relations between clinicians and blood
bank staff through a hospital transfusion committee might
be a possible solution to this.25
The discrepancy between the volumes of blood
requested by clinicians and those crossmatched by blood
bank is likely to be related to the lack of pediatric packs. The
blood bank is probably, and rightly, wary of entering packs
too often to withdraw aliquots of blood because of the risk
of introducing infection. Although there may be additional
expense associated with purchasing small-volume pediatric
packs, this may be offset against better matching of volume
against need and therefore result in less waste. This would
need to be explored in a comparative study. There are also
significant risks of overtransfusion associated with this prac-
tice on wards that are often poorly staffed with a lack of
burettes to aid with monitoring the volumes of blood being
transfused to the children. However, there is some evidence
that the current WHO blood transfusion recommendations
of 20 mL/kg whole blood or 10 mL/kg RBCs may undertreat
a significant proportion of anemic children but further
research is required to build on this evidence.26
A median request-to-issue time of between 3.6 and
5.4 hours is unacceptably prolonged for urgent requests
for blood. This may have been due to shortages of blood
or the perception of unnecessary requests for blood, lead-
ing the blood bank to wait for additional indications that
the blood was really required such as a phone call or ward
staff attending the blood bank in person to chase the
request. This affects patient care as delays in transfusing
these sick children can often lead to adverse outcomes.26
Potential quality improvement interventions would
include introducing a group and save option for clinicians
supported by an agreement by the blood bank to be able
to provide blood within 4 hours if it was requested and cli-
nicians would need to understand that the sample would
be unusable and therefore destroyed after a specific time
had elapsed. In addition, a formal “urgent” request can be
TABLE 5. Comparison of volumes of blood prescribed, requested, and crossmatched in children in whom case
notes were reviewed*
Characteristics Requested Prescribed Crossmatched
Number (%) 442 (75) 410 (69) 367 (62)
Volume (mL), median (IQR) 250 (300) 200 (186) 340 (250)
Range (mL) 10-900 14-900 15-600
Mean (6SD) 300 (6207) 252 (6155) 312 (6146)
<1 unit (%) 293 (66) 334 (81) 193 (53)
1 unit (%) 119 (27) 60 (15) 172 (47)
>1 unit (%) 30 (7) 16 (4) 2 (<1)
Blood volumes (mL/kg)
Number (%) 442 (75) 378 (64) 367 (62)
Volume, median (IQR) 25 (20-39.5) 22.1(20-30) 28.6 (20.5-45)
Range 2.5-360 7.1-66.7 3.3-409.1
*Case notes of 590 children were reviewed.
TRANSFUSIONS IN KENYAN CHILDREN
Volume 00, Month 2016 TRANSFUSION 5
introduced, whereby the blood bank would undertake
to provide blood within 2 hours. Shortages of blood
became less frequent with the establishment of a regional
blood transfusion center on the same campus as the
hospital.
Most of the children who were transfused received
antimalarial therapy irrespective of blood film results. As
donated blood was not routinely screened for malaria in
Kenya at the time of the study, clinicians would have pre-
scribed antimalarials in children receiving blood transfu-
sions due to a perceived risk of transfusion-induced
malaria as recommended in the Kenyan blood transfusion
guidelines.25 This practice although pragmatic, does not
eliminate the risk of transfusion-induced malaria.27-29
This is costly particularly in areas where there is chloro-
quine resistance and artemesinins have to be used.30 It
also contradicts WHO guidance about only using antima-
larials for proven malaria.5 However, there is no suitable
screening test for this in the context of blood donor
screening in endemic areas and eliminating malaria-
positive donors is likely to have a significant effect of
reducing the blood supply and therefore increasing mor-
tality.31 Pathogen inactivation technologies are a potential
solution for the future.32 More research is needed about
how to change the behavior of clinicians to comply with
these changes (e.g., education, better supervision of trans-
fusion practice, blood bank being able to query requests),
how to establish and maintain transfusion committees,
and the cost-effectiveness of introducing specialist trans-
fusion practitioners.
This study has a number of limitations. As we were
not able to access the clinical records of all the children
who had had a request for blood and there was separate
archiving of records of those children that died, we were
not able to estimate the overall survival or mortality out-
comes in relation to the timing and receipt of blood trans-
fusions. In addition, the recording of clinical data in the
records was often incomplete resulting in missing data,
which we have highlighted in our results. These data are
also 8 to 10 years old; however, they are still relevant to
the current operational aspects of pediatric blood transfu-
sions in hospital in Kenya where blood remains scarce, as
the demand is often greater than the supply with a
decrease in blood donors.11 In addition, the KNBTS guide-
lines have not been updated since 2004 and therefore
transfusion-transmitted malaria remains a risk as screen-
ing of blood for malaria parasites is still not national poli-
cy and the recommendation remains to give antimalarial
drugs to recipients of blood shortly after receiving the
transfusion.11 In addition, we have been able to highlight
important areas for intervention that could significantly
improve the processes for pediatric blood transfusions at
the clinical–blood bank interface in this hospital and other
hospitals facing similar challenges in the region.
CONCLUSION AND RECOMMENDATIONS
Our data suggest that in a setting with a high demand for
pediatric transfusion but historically poor supply, clini-
cians tend to overorder blood in terms of both the number
of requests and the volumes requested. This has implica-
tions for laboratory workload and the blood supply itself.
This study provides information on areas that need to be
strengthened within the system for pediatric blood trans-
fusions in this large referral hospital in Kenya and recom-
mendations that can help improve the efficacy and safety
of blood transfusions for children in hospitals in Kenya
and the region. This will ultimately improve the survival
of very sick children who present to hospitals and require
this lifesaving intervention.
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